ArticleJournal of the American Medical Directors Association2024

Evaluating Lecanemab Eligibility for Patients in Skilled Nursing Facilities With Alzheimer Disease or Mild Cognitive Impairment.

Elizabeth G Stettenbauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.